The regulation of coagulation is central to many diseases, including heart disease and stroke. The objective of this research is to better understand the different mechanisms by which the serpins antithrombin (AT) and protein C inhibitor (PCI) inhibit free thrombin, and thrombin bound to thrombomodulin (TM). Specifically, the role of the reactive site loop of PCI in the inhibition of thrombin bound to TM will be examined. A second objective will be to compare the function of the H-helix of PCI with the H-helix of AT.
The first aim of this proposal is to substitute the P3-P3' reactive site loop residues of PCI for those of AT to determine whether the high rates of inactivation are due merely to the reactive site loop differences, or some other portion of PCI.
The second aim i s to determine the role of the H-helix in AT. To do this, glutamate residues in the H-helix of AT will be replaced with arginine and lysine, mimicking the structure of the H-helix in PCI. In the third aim, position 314 of AT will be mutated to an arginine. These proteins will then be assayed with thrombin in the presence and absence of TM to determine whether these mutations alter the activity of AT. The outcome of these experiments may provide a clearer understanding of the different mechanisms by which PCI and AT inhibit thrombin complexed with TM.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15HL058222-01
Application #
2031426
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1997-06-01
Project End
2001-05-31
Budget Start
1997-06-01
Budget End
2001-05-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Wisconsin la Crosse
Department
Biology
Type
Schools of Allied Health Profes
DUNS #
068191097
City
La Crosse
State
WI
Country
United States
Zip Code
54601
Gonzales, Patrick R; Walston, Timothy D; Camacho, Laureano O et al. (2007) Mutation of the H-helix in antithrombin decreases heparin stimulation of protease inhibition. Biochim Biophys Acta 1774:1431-7
Fortenberry, Y M; Whinna, H C; Cooper, S T et al. (2007) Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin and thrombomodulin. J Thromb Haemost 5:1486-92
Rehault, Sophie M; Zechmeister-Machhart, Margareta; Fortenberry, Yolanda M et al. (2005) Characterization of recombinant human protein C inhibitor expressed in Escherichia coli. Biochim Biophys Acta 1748:57-65
Yang, Likui; Manithody, Chandrashekhara; Walston, Timothy D et al. (2003) Thrombomodulin enhances the reactivity of thrombin with protein C inhibitor by providing both a binding site for the serpin and allosterically modulating the activity of thrombin. J Biol Chem 278:37465-70